Company Filing History:
Years Active: 1998-1999
Title: Inventor Spotlight: Alan R. Friedman
Introduction: Alan R. Friedman is a notable inventor based in Portage, Michigan, known for his contributions to pharmaceutical innovations. With a total of two patents, he has significantly impacted the field of anthelmintic compounds and growth hormone release.
Latest Patents: Friedman’s latest patents showcase his innovative approaches in biochemistry. The first patent is titled "Method for discovering novel anthelmintic compounds," which introduces a novel radioactive neuropeptide represented by the formula Lys-His-Glu-Tyr.sup.--I -Leu-Arg-Phe-amide. This invention presents a groundbreaking method for detecting anthelmintic activity of compounds through a receptor binding assay, demonstrating potent bioactivity in Ascaris suum neuromuscular strips. Consequently, it offers immense potential for high-volume screening of new anthelmintic compounds. The second patent, "Stabilized potent GRF analogs," details novel GRF peptides that possess enhanced stability in plasma. These peptides contain specific amino acid configurations designed to stimulate the release of growth hormone effectively.
Career Highlights: Alan R. Friedman currently works with the Pharmacia & Upjohn Company, a prominent organization in the pharmaceutical industry. His dedication to research and development has cemented his status as an influential figure in the field.
Collaborations: Throughout his career, Friedman has collaborated with esteemed colleagues such as Teresa M. Kubiak and Timothy G. Geary. These collaborations have facilitated the advancement of his innovative projects and have contributed to the overall success of his patents.
Conclusion: Alan R. Friedman’s inventive spirit and dedication to pharmaceutical research have led to significant advancements in the development of anthelmintic compounds and growth hormones. His contributions not only highlight his prowess as an inventor but also underscore the importance of collaboration in fostering innovation within the industry.